Veradigm (NASDAQ:MDRX) Stock Price Down 8% – Here’s Why

Veradigm Inc. (NASDAQ:MDRX)’s stock price traded down 8% during trading on Monday . The stock traded as low as $4.53 and last traded at $4.60. 1,056 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 158,328 shares. The stock had previously closed at $5.00.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Stock Performance

The company has a 50 day simple moving average of $4.80 and a two-hundred day simple moving average of $4.67. The company has a market cap of $623.73 million, a PE ratio of 23.25 and a beta of 0.55.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.